When NGIO was incorporated, 750,000,000 authorized common shares and 10,000,000 preferred shares were created. Before the GNBT swap, 400,300,000 shares were outstanding, including the shares GNBT owned, and 349,700,000 shares remained in the NGIO corporate treasury. After the GNBT swap, the 300,000,000 shares were returned to the NGIO treasury (not destroyed) to (re)sold/issued as needed in the future for additional capital. So the current total count is 649,700,000 treasury shares and 100,300,000 outstanding shares equaling (still) 750,000,000 total corporate authorized shares. See NGIO 10-K page F-3
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links